The DOI matches its Crossref record; 455 of the 455 references it cites were found in a registry or an index.
Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections
Open accessAbstract
ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species) are among the most common opportunistic pathogens in nosocomial infections. ESKAPE pathogens distinguish themselves from normal ones by developing a high level of antibiotic resistance that involves multiple mechanisms. Contemporary therapeutic strategies which are potential options in combating ESKAPE bacteria need further investigation. Herein, a broad overview of the antimicrobial research on ESKAPE pathogens over the past five years is provided with prospective clinical applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Magiorakos, A.-P., Srinivasan, A., Carey, R. B., Carmeli, Y., Falagas, M. E., Giske, C. G., Harbarth, S., Hindler, J. F., Kahlmeter, G., Olsson-Liljequist, B., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03570.x · Cited by 14,449
Biofilms: an emergent form of bacterial life
Flemming, H.-C., Wingender, J., Szewzyk, U., Steinberg, P., Rice, S. A., & Kjelleberg, S. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.94 · Cited by 5,979
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
Flores-Mireles, A. L., Walker, J. N., Caparon, M., & Hultgren, S. J. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3432 · Cited by 4,213
Antimicrobial resistance: a global multifaceted phenomenon
Prestinaci, F., Pezzotti, P., & Pantosti, A. (2015) · Pathogens and Global Health · doi:10.1179/2047773215y.0000000030 · Cited by 3,296
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
Klein, E. Y., Van Boeckel, T. P., Martinez, E. M., Pant, S., Gandra, S., Levin, S. A., Goossens, H., & Laxminarayan, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717295115 · Cited by 3,232
Understanding the mechanisms and drivers of antimicrobial resistance
Holmes, A. H., Moore, L. S. P., Sundsfjord, A., Steinbakk, M., Regmi, S., Karkey, A., Guerin, P. J., & Piddock, L. J. V. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00473-0 · Cited by 2,611
A new antibiotic kills pathogens without detectable resistance
Ling, L. L., Schneider, T., Peoples, A. J., Spoering, A. L., Engels, I., Conlon, B. P., Mueller, A., Schäberle, T. F., Hughes, D. E., Epstein, S., et al. (2015) · Nature · doi:10.1038/nature14098 · Cited by 2,428
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
Quorum sensing signal-response systems in Gram-negative bacteria
Papenfort, K., & Bassler, B. L. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.89 · Cited by 2,256
Antimicrobial Peptides: An Emerging Category of Therapeutic Agents
Mahlapuu, M., Håkansson, J., Ringstad, L., & Björn, C. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00194 · Cited by 1,927
Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens
Santajit, S., & Indrawattana, N. (2016) · BioMed Research International · doi:10.1155/2016/2475067 · Cited by 1,641
β-Lactams and β-Lactamase Inhibitors: An Overview
Bush, K., & Bradford, P. A. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025247 · Cited by 1,412
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
Graphene-based nanomaterials for drug delivery and tissue engineering
Goenka, S., Sant, V., & Sant, S. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.10.017 · Cited by 1,311
Schooley, R. T., Biswas, B., Gill, J. J., Hernandez-Morales, A., Lancaster, J., Lessor, L., Barr, J. J., Reed, S. L., Rohwer, F., Benler, S., et al. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00954-17 · Cited by 1,254
Krause, K. M., Serio, A. W., Kane, T. R., & Connolly, L. E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027029 · Cited by 1,149
Zhang, L.-J., & Gallo, R. L. (2016) · Current Biology · doi:10.1016/j.cub.2015.11.017 · Cited by 1,029
Jault, P., Leclerc, T., Jennes, S., Pirnay, J. P., Que, Y.-A., Resch, G., Rousseau, A. F., Ravat, F., Carsin, H., Le Floch, R., et al. (2019) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30482-1 · Cited by 874
The negative impact of antibiotic resistance
Friedman, N. D., Temkin, E., & Carmeli, Y. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.12.002 · Cited by 870
A Review on Antibiotic Resistance: Alarm Bells are Ringing
Zaman, S. B., Hussain, M. A., Nye, R., Mehta, V., Mamun, K. T., & Hossain, N. (2017) · Cureus · doi:10.7759/cureus.1403 · Cited by 854
Novel antibody-antibiotic conjugate eliminates intracellular S. aureus
Lehar, S. M., Pillow, T., Xu, M., Staben, L., Kajihara, K. K., Vandlen, R., DePalatis, L., Raab, H., Hazenbos, W. L., Hiroshi Morisaki, J., et al. (2015) · Nature · doi:10.1038/nature16057 · Cited by 838
Lam, S. J., O'Brien-Simpson, N. M., Pantarat, N., Sulistio, A., Wong, E. H. H., Chen, Y.-Y., Lenzo, J. C., Holden, J. A., Blencowe, A., Reynolds, E. C., et al. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.162 · Cited by 821
Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance
Dickey, S. W., Cheung, G. Y. C., & Otto, M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.23 · Cited by 799
Harris, P. N. A., Tambyah, P. A., Lye, D. C., Mo, Y., Lee, T. H., Yilmaz, M., Alenazi, T. H., Arabi, Y., Falcone, M., Bassetti, M., et al. (2018) · JAMA · doi:10.1001/jama.2018.12163 · Cited by 774
Application of liposomes in medicine and drug delivery
Daraee, H., Etemadi, A., Kouhi, M., Alimirzalu, S., & Akbarzadeh, A. (2016) · Artificial Cells, Nanomedicine, and Biotechnology · doi:10.3109/21691401.2014.953633 · Cited by 765
A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation
O’Loughlin, C. T., Miller, L. C., Siryaporn, A., Drescher, K., Semmelhack, M. F., & Bassler, B. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316981110 · Cited by 744
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
Andersson, D. I., Hughes, D., & Kubicek-Sutherland, J. Z. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.04.002 · Cited by 715
Founou, R. C., Founou, L. L., & Essack, S. Y. (2017) · PLOS ONE · doi:10.1371/journal.pone.0189621 · Cited by 710
The global distribution and spread of the mobilized colistin resistance gene mcr-1
Wang, R., van Dorp, L., Shaw, L. P., Bradley, P., Wang, Q., Wang, X., Jin, L., Zhang, Q., Liu, Y., Rieux, A., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03205-z · Cited by 662
Antibacterial activity of flavonoids and their structure–activity relationship: An update review
Farhadi, F., Khameneh, B., Iranshahi, M., & Iranshahy, M. (2019) · Phytotherapy Research · doi:10.1002/ptr.6208 · Cited by 636
Unusual Amino Acids in Medicinal Chemistry
Blaskovich, M. A. T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00319 · Cited by 635
Natural Products as Platforms To Overcome Antibiotic Resistance
Rossiter, S. E., Fletcher, M. H., & Wuest, W. M. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00283 · Cited by 622
Ageitos, J. M., Sánchez-Pérez, A., Calo-Mata, P., & Villa, T. G. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2016.09.018 · Cited by 614
ESKAPEing the labyrinth of antibacterial discovery
Tommasi, R., Brown, D. G., Walkup, G. K., Manchester, J. I., & Miller, A. A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4572 · Cited by 608
Antibiotic Adjuvants: Rescuing Antibiotics from Resistance
Wright, G. D. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.06.009 · Cited by 604
Formulation, stabilisation and encapsulation of bacteriophage for phage therapy
Malik, D. J., Sokolov, I. J., Vinner, G. K., Mancuso, F., Cinquerrui, S., Vladisavljevic, G. T., Clokie, M. R. J., Garton, N. J., Stapley, A. G. F., & Kirpichnikova, A. (2017) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2017.05.014 · Cited by 594
Functions and emerging applications of bacteriocins
Chikindas, M. L., Weeks, R., Drider, D., Chistyakov, V. A., & Dicks, L. M. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.07.011 · Cited by 574
van Duin, D., & Bonomo, R. A. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw243 · Cited by 549
Ligand-targeted liposome design: challenges and fundamental considerations
Noble, G. T., Stefanick, J. F., Ashley, J. D., Kiziltepe, T., & Bilgicer, B. (2014) · Trends in Biotechnology · doi:10.1016/j.tibtech.2013.09.007 · Cited by 542
Human Antimicrobial Peptides and Proteins
Wang, G. (2014) · Pharmaceuticals · doi:10.3390/ph7050545 · Cited by 528
Plant Natural Products Targeting Bacterial Virulence Factors
Silva, L. N., Zimmer, K. R., Macedo, A. J., & Trentin, D. S. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00184 · Cited by 504
Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections
Hu, X., Huang, Y.-Y., Wang, Y., Wang, X., & Hamblin, M. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01299 · Cited by 502
Phage treatment of an aortic graft infected with Pseudomonas aeruginosa
Chan, B. K., Turner, P. E., Kim, S., Mojibian, H. R., Elefteriades, J. A., & Narayan, D. (2018) · Evolution, Medicine, and Public Health · doi:10.1093/emph/eoy005 · Cited by 501
Roach, D. R., Leung, C. Y., Henry, M., Morello, E., Singh, D., Di Santo, J. P., Weitz, J. S., & Debarbieux, L. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.06.018 · Cited by 484
Antimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
Pfalzgraff, A., Brandenburg, K., & Weindl, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00281 · Cited by 481
Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09
Shapiro, D. J., Hicks, L. A., Pavia, A. T., & Hersh, A. L. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt301 · Cited by 466
Lipid and polymer nanoparticles for drug delivery to bacterial biofilms
Forier, K., Raemdonck, K., De Smedt, S. C., Demeester, J., Coenye, T., & Braeckmans, K. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.055 · Cited by 464
Polymyxin: Alternative Mechanisms of Action and Resistance
Trimble, M. J., Mlynárčik, P., Kolář, M., & Hancock, R. E. W. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a025288 · Cited by 454
Torres, A., Zhong, N., Pachl, J., Timsit, J.-F., Kollef, M., Chen, Z., Song, J., Taylor, D., Laud, P. J., Stone, G. G., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30747-8 · Cited by 441
Ahmed, M. O., & Baptiste, K. E. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0147 · Cited by 438
Solomkin, J., Hershberger, E., Miller, B., Popejoy, M., Friedland, I., Steenbergen, J., Yoon, M., Collins, S., Yuan, G., Barie, P. S., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ097 · Cited by 420
Quorum Sensing Inhibitors as Anti-Biofilm Agents
Brackman, G., & Coenye, T. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140905114627 · Cited by 420
Escherichia coli biofilm: development and therapeutic strategies
Sharma, G., Sharma, S., Sharma, P., Chandola, D., Dang, S., Gupta, S., & Gabrani, R. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13078 · Cited by 420
Portsmouth, S., van Veenhuyzen, D., Echols, R., Machida, M., Ferreira, J. C. A., Ariyasu, M., Tenke, P., & Nagata, T. D. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30554-1 · Cited by 420
Carmeli, Y., Armstrong, J., Laud, P. J., Newell, P., Stone, G., Wardman, A., & Gasink, L. B. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30004-4 · Cited by 417
A cell-cell communication signal integrates quorum sensing and stress response
Lee, J., Wu, J., Deng, Y., Wang, J., Wang, C., Wang, J., Chang, C., Dong, Y., Williams, P., & Zhang, L.-H. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1225 · Cited by 416
Self-citationAntimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria
Moravej, H., Moravej, Z., Yazdanparast, M., Heiat, M., Mirhosseini, A., Moosazadeh Moghaddam, M., & Mirnejad, R. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0392 · Cited by 410
Multidrug Resistant and Extensively Drug Resistant Bacteria: A Study
Basak, S., Singh, P., & Rajurkar, M. (2016) · Journal of Pathogens · doi:10.1155/2016/4065603 · Cited by 395
Peptides with Dual Antimicrobial and Anticancer Activities
Felício, M. R., Silva, O. N., Gonçalves, S., Santos, N. C., & Franco, O. L. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00005 · Cited by 393
Chandra, H., Bishnoi, P., Yadav, A., Patni, B., Mishra, A., & Nautiyal, A. (2017) · Plants · doi:10.3390/plants6020016 · Cited by 389
Wagenlehner, F. M., Umeh, O., Steenbergen, J., Yuan, G., & Darouiche, R. O. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62220-0 · Cited by 388
Urinary Tract Infection: Pathogenesis and Outlook
McLellan, L. K., & Hunstad, D. A. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.09.003 · Cited by 382
Zhanel, G. G., Lawrence, C. K., Adam, H., Schweizer, F., Zelenitsky, S., Zhanel, M., Lagacé-Wiens, P. R. S., Walkty, A., Denisuik, A., Golden, A., et al. (2018) · Drugs · doi:10.1007/s40265-017-0851-9 · Cited by 377
Development of botanicals to combat antibiotic resistance
Gupta, P. D., & Birdi, T. J. (2017) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2017.05.004 · Cited by 371
Wagenlehner, F. M., Sobel, J. D., Newell, P., Armstrong, J., Huang, X., Stone, G. G., Yates, K., & Gasink, L. B. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw378 · Cited by 362
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
Brown, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4675 · Cited by 359
Anderson, D. J., Chen, L. F., Weber, D. J., Moehring, R. W., Lewis, S. S., Triplett, P. F., Blocker, M., Becherer, P., Schwab, J. C., Knelson, L. P., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31588-4 · Cited by 357
Optimized arylomycins are a new class of Gram-negative antibiotics
Smith, P. A., Koehler, M. F. T., Girgis, H. S., Yan, D., Chen, Y., Chen, Y., Crawford, J. J., Durk, M. R., Higuchi, R. I., Kang, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0483-6 · Cited by 355
Nation, R. L., Li, J., Cars, O., Couet, W., Dudley, M. N., Kaye, K. S., Mouton, J. W., Paterson, D. L., Tam, V. H., Theuretzbacher, U., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70850-3 · Cited by 354
Self-citationMcGann, P., Snesrud, E., Maybank, R., Corey, B., Ong, A. C., Clifford, R., Hinkle, M., Whitman, T., Lesho, E., & Schaecher, K. E. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01103-16 · Cited by 350
Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy
Tagliaferri, T. L., Jansen, M., & Horz, H.-P. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00022 · Cited by 345
Kashef, N., & Hamblin, M. R. (2017) · Drug Resistance Updates · doi:10.1016/j.drup.2017.07.003 · Cited by 343
Chin, W., Zhong, G., Pu, Q., Yang, C., Lou, W., De Sessions, P. F., Periaswamy, B., Lee, A., Liang, Z. C., Ding, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03325-6 · Cited by 331
Oechslin, F., Piccardi, P., Mancini, S., Gabard, J., Moreillon, P., Entenza, J. M., Resch, G., & Que, Y.-A. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiw632 · Cited by 325
Antibiotic Adjuvants: Diverse Strategies for Controlling Drug‐Resistant Pathogens
Gill, E. E., Franco, O. L., & Hancock, R. E. W. (2015) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12478 · Cited by 319
Cisek, A. A., Dąbrowska, I., Gregorczyk, K. P., & Wyżewski, Z. (2017) · Current Microbiology · doi:10.1007/s00284-016-1166-x · Cited by 318
Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent
Zhanel, G. G., Cheung, D., Adam, H., Zelenitsky, S., Golden, A., Schweizer, F., Gorityala, B., Lagacé-Wiens, P. R. S., Walkty, A., Gin, A. S., et al. (2016) · Drugs · doi:10.1007/s40265-016-0545-8 · Cited by 317
Kaye, K. S., Bhowmick, T., Metallidis, S., Bleasdale, S. C., Sagan, O. S., Stus, V., Vazquez, J., Zaitsev, V., Bidair, M., Chorvat, E., et al. (2018) · JAMA · doi:10.1001/jama.2018.0438 · Cited by 314
Revisiting phage therapy: new applications for old resources
Nobrega, F. L., Costa, A. R., Kluskens, L. D., & Azeredo, J. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.01.006 · Cited by 310
Moran, G. J., Fang, E., Corey, G. R., Das, A. F., De Anda, C., & Prokocimer, P. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70737-6 · Cited by 309
Evolutionary Rationale for Phages as Complements of Antibiotics
Torres-Barceló, C., & Hochberg, M. E. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2015.12.011 · Cited by 308
Resistance in antimicrobial photodynamic inactivation of bacteria
Maisch, T. (2015) · Photochemical & Photobiological Sciences · doi:10.1039/c5pp00037h · Cited by 307
Fleitas Martínez, O., Cardoso, M. H., Ribeiro, S. M., & Franco, O. L. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00074 · Cited by 304
Control of Biofilm Formation: Antibiotics and Beyond
Algburi, A., Comito, N., Kashtanov, D., Dicks, L. M. T., & Chikindas, M. L. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.02508-16 · Cited by 299
Host defense antimicrobial peptides as antibiotics: design and application strategies
Mishra, B., Reiling, S., Zarena, D., & Wang, G. (2017) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2017.03.014 · Cited by 299
Antimicrobial peptides as potential anti-biofilm agents against multidrug-resistant bacteria
Chung, P. Y., & Khanum, R. (2017) · Journal of Microbiology, Immunology and Infection · doi:10.1016/j.jmii.2016.12.005 · Cited by 296
Esmaeili, A., & Asgari, A. (2015) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2015.08.010 · Cited by 295
de Faria, A. F., Perreault, F., Shaulsky, E., Arias Chavez, L. H., & Elimelech, M. (2015) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5b01639 · Cited by 291
Shrestha, P., Cooper, B. S., Coast, J., Oppong, R., Do Thi Thuy, N., Phodha, T., Celhay, O., Guerin, P. J., Wertheim, H., & Lubell, Y. (2018) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-018-0384-3 · Cited by 288
Durand-Réville, T. F., Guler, S., Comita-Prevoir, J., Chen, B., Bifulco, N., Huynh, H., Lahiri, S., Shapiro, A. B., McLeod, S. M., Carter, N. M., et al. (2017) · Nature Microbiology · doi:10.1038/nmicrobiol.2017.104 · Cited by 285
An overview of antimicrobial peptides and the latest advances in their development
Sierra, J. M., Fusté, E., Rabanal, F., Vinuesa, T., & Viñas, M. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2017.1315402 · Cited by 283
A multifunctional bispecific antibody protects against Pseudomonas aeruginosa
DiGiandomenico, A., Keller, A. E., Gao, C., Rainey, G. J., Warrener, P., Camara, M. M., Bonnell, J., Fleming, R., Bezabeh, B., Dimasi, N., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009655 · Cited by 277
Quality and Safety Requirements for Sustainable Phage Therapy Products
Pirnay, J.-P., Blasdel, B. G., Bretaudeau, L., Buckling, A., Chanishvili, N., Clark, J. R., Corte-Real, S., Debarbieux, L., Dublanchet, A., De Vos, D., et al. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1617-7 · Cited by 276
Imperial, I. C. V. J., & Ibana, J. A. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01983 · Cited by 276
Recent advances toward a molecular mechanism of efflux pump inhibition
Opperman, T. J., & Nguyen, S. T. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00421 · Cited by 266
Developments in Glycopeptide Antibiotics
Blaskovich, M. A. T., Hansford, K. A., Butler, M. S., Jia, Z., Mark, A. E., & Cooper, M. A. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00258 · Cited by 265
Novel Strategies for the Treatment of Pseudomonas aeruginosa Infections
Wagner, S., Sommer, R., Hinsberger, S., Lu, C., Hartmann, R. W., Empting, M., & Titz, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01698 · Cited by 258
Yousefi, M., Dadashpour, M., Hejazi, M., Hasanzadeh, M., Behnam, B., de la Guardia, M., Shadjou, N., & Mokhtarzadeh, A. (2017) · Materials Science and Engineering: C · doi:10.1016/j.msec.2016.12.125 · Cited by 258
Ferreira, R. L., da Silva, B. C. M., Rezende, G. S., Nakamura-Silva, R., Pitondo-Silva, A., Campanini, E. B., Brito, M. C. A., da Silva, E. M. L., Freire, C. C. D. M., Cunha, A. F. D., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03198 · Cited by 257
Role of AcrAB-TolC multidrug efflux pump in drug-resistance acquisition by plasmid transfer
Nolivos, S., Cayron, J., Dedieu, A., Page, A., Delolme, F., & Lesterlin, C. (2019) · Science · doi:10.1126/science.aav6390 · Cited by 257
Antibiotic adjuvants – A strategy to unlock bacterial resistance to antibiotics
González-Bello, C. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.08.027 · Cited by 254
Chua, K.-P., Fischer, M. A., & Linder, J. A. (2019) · BMJ · doi:10.1136/bmj.k5092 · Cited by 251
The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?
Melander, R. J., & Melander, C. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00071 · Cited by 250
Jennes, S., Merabishvili, M., Soentjens, P., Pang, K. W., Rose, T., Keersebilck, E., Soete, O., François, P.-M., Teodorescu, S., Verween, G., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1709-y · Cited by 248
Phage Therapy for a Multidrug-Resistant Acinetobacter baumannii Craniectomy Site Infection
LaVergne, S., Hamilton, T., Biswas, B., Kumaraswamy, M., Schooley, R. T., & Wooten, D. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy064 · Cited by 239
Trimethoprim–Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess
Talan, D. A., Mower, W. R., Krishnadasan, A., Abrahamian, F. M., Lovecchio, F., Karras, D. J., Steele, M. T., Rothman, R. E., Hoagland, R., & Moran, G. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1507476 · Cited by 236
Omadacycline for Community-Acquired Bacterial Pneumonia
Stets, R., Popescu, M., Gonong, J. R., Mitha, I., Nseir, W., Madej, A., Kirsch, C., Das, A. F., Garrity-Ryan, L., Steenbergen, J. N., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1800201 · Cited by 235
Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective
Mathur, H., Field, D., Rea, M. C., Cotter, P. D., Hill, C., & Ross, R. P. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01205 · Cited by 233
The Mortality Burden of Multidrug-resistant Pathogens in India: A Retrospective, Observational Study
Gandra, S., Tseng, K. K., Arora, A., Bhowmik, B., Robinson, M. L., Panigrahi, B., Laxminarayan, R., & Klein, E. Y. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciy955 · Cited by 227
Narrow-spectrum antibacterial agents
Melander, R. J., Zurawski, D. V., & Melander, C. (2018) · MedChemComm · doi:10.1039/c7md00528h · Cited by 226
Non-Membrane Permeabilizing Modes of Action of Antimicrobial Peptides on Bacteria
Scocchi, M., Mardirossian, M., Runti, G., & Benincasa, M. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150703121009 · Cited by 225
Teklu, D. S., Negeri, A. A., Legese, M. H., Bedada, T. L., Woldemariam, H. K., & Tullu, K. D. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0488-4 · Cited by 224
Tiwari, S., Jamal, S. B., Hassan, S. S., Carvalho, P. V. S. D., Almeida, S., Barh, D., Ghosh, P., Silva, A., Castro, T. L. P., & Azevedo, V. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01878 · Cited by 223
Rai, M., Paralikar, P., Jogee, P., Agarkar, G., Ingle, A. P., Derita, M., & Zacchino, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.01.013 · Cited by 222
A brief history of antibiotics and select advances in their synthesis
Nicolaou, K. C., & Rigol, S. (2018) · The Journal of Antibiotics · doi:10.1038/ja.2017.62 · Cited by 222
Cell-Wall Recycling of the Gram-Negative Bacteria and the Nexus to Antibiotic Resistance
Dik, D. A., Fisher, J. F., & Mobashery, S. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00277 · Cited by 221
Once-Daily Plazomicin for Complicated Urinary Tract Infections
Wagenlehner, F. M. E., Cloutier, D. J., Komirenko, A. S., Cebrik, D. S., Krause, K. M., Keepers, T. R., Connolly, L. E., Miller, L. G., Friedland, I., & Dwyer, J. P. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1801467 · Cited by 218
Sanyasi, S., Majhi, R. K., Kumar, S., Mishra, M., Ghosh, A., Suar, M., Satyam, P. V., Mohapatra, H., Goswami, C., & Goswami, L. (2016) · Scientific Reports · doi:10.1038/srep24929 · Cited by 215
Fighting biofilms with lantibiotics and other groups of bacteriocins
Mathur, H., Field, D., Rea, M. C., Cotter, P. D., Hill, C., & Ross, R. P. (2018) · npj Biofilms and Microbiomes · doi:10.1038/s41522-018-0053-6 · Cited by 213
Howlin, R. P., Cathie, K., Hall-Stoodley, L., Cornelius, V., Duignan, C., Allan, R. N., Fernandez, B. O., Barraud, N., Bruce, K. D., Jefferies, J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.06.021 · Cited by 209
Synergistic Effects between Conventional Antibiotics and 2-Aminoimidazole-Derived Antibiofilm Agents
Rogers, S. A., Huigens, R. W., Cavanagh, J., & Melander, C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01418-09 · Cited by 205
Knezevic, P., Aleksic, V., Simin, N., Svircev, E., Petrovic, A., & Mimica-Dukic, N. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.12.008 · Cited by 205
A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses
Daum, R. S., Miller, L. G., Immergluck, L., Fritz, S., Creech, C. B., Young, D., Kumar, N., Downing, M., Pettibone, S., Hoagland, R., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607033 · Cited by 204
Characterization of a Novel Pyranopyridine Inhibitor of the AcrAB Efflux Pump of Escherichia coli
Opperman, T. J., Kwasny, S. M., Kim, H.-S., Nguyen, S. T., Houseweart, C., D'Souza, S., Walker, G. C., Peet, N. P., Nikaido, H., & Bowlin, T. L. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01866-13 · Cited by 202
Wakaskar, R. R. (2018) · Journal of Drug Targeting · doi:10.1080/1061186x.2017.1367006 · Cited by 201
Two-component systems required for virulence in Pseudomonas aeruginosa
Francis, V. I., Stevenson, E. C., & Porter, S. L. (2017) · FEMS Microbiology Letters · doi:10.1093/femsle/fnx104 · Cited by 199
Thwaites, G. E., Scarborough, M., Szubert, A., Nsutebu, E., Tilley, R., Greig, J., Wyllie, S. A., Wilson, P., Auckland, C., Cairns, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32456-x · Cited by 199
Anti-virulence Strategies to Target Bacterial Infections
Mühlen, S., & Dersch, P. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2015_490 · Cited by 198
Gonzalez, M. E., Schaffer, J. V., Orlow, S. J., Gao, Z., Li, H., Alekseyenko, A. V., & Blaser, M. J. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.04.066 · Cited by 195
Evolution of Resistance to Quorum-Sensing Inhibitors
Kalia, V. C., Wood, T. K., & Kumar, P. (2014) · Microbial Ecology · doi:10.1007/s00248-013-0316-y · Cited by 192
Current Trends in Development of Liposomes for Targeting Bacterial Biofilms
Rukavina, Z., & Vanić, Ž. (2016) · Pharmaceutics · doi:10.3390/pharmaceutics8020018 · Cited by 192
High Antibacterial Activity of Functionalized Chemically Exfoliated MoS2
Pandit, S., Karunakaran, S., Boda, S. K., Basu, B., & De, M. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b10916 · Cited by 191
The disparate effects of bacteriophages on antibiotic-resistant bacteria
Torres-Barceló, C. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0169-z · Cited by 189
De Soyza, A., Aksamit, T., Bandel, T.-J., Criollo, M., Elborn, J. S., Operschall, E., Polverino, E., Roth, K., Winthrop, K. L., & Wilson, R. (2018) · European Respiratory Journal · doi:10.1183/13993003.02052-2017 · Cited by 188
Aksamit, T., De Soyza, A., Bandel, T.-J., Criollo, M., Elborn, J. S., Operschall, E., Polverino, E., Roth, K., Winthrop, K. L., & Wilson, R. (2018) · European Respiratory Journal · doi:10.1183/13993003.02053-2017 · Cited by 188
Nanoparticle-Stabilized Capsules for the Treatment of Bacterial Biofilms
Duncan, B., Li, X., Landis, R. F., Kim, S. T., Gupta, A., Wang, L.-S., Ramanathan, R., Tang, R., Boerth, J. A., & Rotello, V. M. (2015) · ACS Nano · doi:10.1021/acsnano.5b01696 · Cited by 187
Regeimbal, J. M., Jacobs, A. C., Corey, B. W., Henry, M. S., Thompson, M. G., Pavlicek, R. L., Quinones, J., Hannah, R. M., Ghebremedhin, M., Crane, N. J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02877-15 · Cited by 187
Mechanisms and Targeted Therapies for Pseudomonas aeruginosa Lung Infection
Curran, C. S., Bolig, T., & Torabi-Parizi, P. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201705-1043so · Cited by 182
Agnihotri, S., Bajaj, G., Mukherji, S., & Mukherji, S. (2015) · Nanoscale · doi:10.1039/c4nr06913g · Cited by 180
Predicting drug resistance evolution: insights from antimicrobial peptides and antibiotics
Yu, G., Baeder, D. Y., Regoes, R. R., & Rolff, J. (2018) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2017.2687 · Cited by 178
Decolonization to Reduce Postdischarge Infection Risk among MRSA Carriers
Huang, S. S., Singh, R., McKinnell, J. A., Park, S., Gombosev, A., Eells, S. J., Gillen, D. L., Kim, D., Rashid, S., Macias-Gil, R., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1716771 · Cited by 178
Bacteriophage Therapy: Advances in Formulation Strategies and Human Clinical Trials
Vandenheuvel, D., Lavigne, R., & Brüssow, H. (2015) · Annual Review of Virology · doi:10.1146/annurev-virology-100114-054915 · Cited by 176
Plant phenolics and terpenoids as adjuvants of antibacterial and antifungal drugs
Zacchino, S. A., Butassi, E., Liberto, M. D., Raimondi, M., Postigo, A., & Sortino, M. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.10.018 · Cited by 175
Ansari, M. A., Khan, H. M., Khan, A. A., Cameotra, S. S., & Pal, R. (2014) · Applied Nanoscience · doi:10.1007/s13204-013-0266-1 · Cited by 174
Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases
Niyonsaba, F., Kiatsurayanon, C., Chieosilapatham, P., & Ogawa, H. (2017) · Experimental Dermatology · doi:10.1111/exd.13314 · Cited by 174
Frees, D., Gerth, U., & Ingmer, H. (2014) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.11.009 · Cited by 171
Immobilized photosensitizers for antimicrobial applications
Spagnul, C., Turner, L. C., & Boyle, R. W. (2015) · Journal of Photochemistry and Photobiology B: Biology · doi:10.1016/j.jphotobiol.2015.04.021 · Cited by 171
Human milk oligosaccharides inhibit growth of group B Streptococcus
Lin, A. E., Autran, C. A., Szyszka, A., Escajadillo, T., Huang, M., Godula, K., Prudden, A. R., Boons, G.-J., Lewis, A. L., Doran, K. S., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.789974 · Cited by 169
Talà, L., Fineberg, A., Kukura, P., & Persat, A. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0378-9 · Cited by 169
Phillips, J. W., Goetz, M. A., Smith, S. K., Zink, D. L., Polishook, J., Onishi, R., Salowe, S., Wiltsie, J., Allocco, J., Sigmund, J., et al. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.06.011 · Cited by 168
Antimicrobial peptides: promising compounds against pathogenic microorganisms
Cruz, J., Ortiz, C., Guzmán, F., Fernández-Lafuente, R., & Torres, R. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666140217110155 · Cited by 166
Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003–2015)
Kosikowska, P., & Lesner, A. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2016.1176149 · Cited by 165
Meeker, D. G., Jenkins, S. V., Miller, E. K., Beenken, K. E., Loughran, A. J., Powless, A., Muldoon, T. J., Galanzha, E. I., Zharov, V. P., Smeltzer, M. S., et al. (2016) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5b00117 · Cited by 163
Self-citationAdapted Bacteriophages for Treating Urinary Tract Infections
Ujmajuridze, A., Chanishvili, N., Goderdzishvili, M., Leitner, L., Mehnert, U., Chkhotua, A., Kessler, T. M., & Sybesma, W. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01832 · Cited by 163
Panáček, A., Smékalová, M., Večeřová, R., Bogdanová, K., Röderová, M., Kolář, M., Kilianová, M., Hradilová, Š., Froning, J. P., Havrdová, M., et al. (2016) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2016.03.007 · Cited by 161
Safety and efficacy of phage therapy via the intravenous route
Speck, P., & Smithyman, A. (2016) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv242 · Cited by 160
Cao, F., Wang, X., Wang, L., Li, Z., Che, J., Wang, L., Li, X., Cao, Z., Zhang, J., Jin, L., et al. (2015) · BioMed Research International · doi:10.1155/2015/752930 · Cited by 159
Considerations and caveats in anti-virulence drug development
Maura, D., Ballok, A. E., & Rahme, L. G. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.06.001 · Cited by 159
Perspectives for clinical use of engineered human host defense antimicrobial peptides
Pachón-Ibáñez, M. E., Smani, Y., Pachón, J., & Sánchez-Céspedes, J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux012 · Cited by 159
Cano, V., March, C., Insua, J. L., Aguiló, N., Llobet, E., Moranta, D., Regueiro, V., Brennan, G. P., Millán-Lou, M. I., Martín, C., et al. (2015) · Cellular Microbiology · doi:10.1111/cmi.12466 · Cited by 158
Omadacycline for Acute Bacterial Skin and Skin-Structure Infections
O’Riordan, W., Green, S., Overcash, J. S., Puljiz, I., Metallidis, S., Gardovskis, J., Garrity-Ryan, L., Das, A. F., Tzanis, E., Eckburg, P. B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1800170 · Cited by 158
Appropriate antimicrobial therapy in the era of multidrug-resistant human pathogens
Pogue, J. M., Kaye, K. S., Cohen, D. A., & Marchaim, D. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2014.12.025 · Cited by 156
Huang, S. S., Septimus, E. J., Kleinman, K., Moody, J. A., Hickok, J. D., Heim, L. T., Gombosev, A., Avery, T. R., Haffenreffer, K., Shimelman, L., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32593-5 · Cited by 156
Wan, G., Ruan, L., Yin, Y., Yang, T., Ge, M., & Cheng, X. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s104166 · Cited by 155
Laser-induced vapour nanobubbles improve drug diffusion and efficiency in bacterial biofilms
Teirlinck, E., Xiong, R., Brans, T., Forier, K., Fraire, J., Van Acker, H., Matthijs, N., De Rycke, R., De Smedt, S. C., Coenye, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06884-w · Cited by 154
Genetic control of bacterial biofilms
Wolska, K. I., Grudniak, A. M., Rudnicka, Z., & Markowska, K. (2016) · Journal of Applied Genetics · doi:10.1007/s13353-015-0309-2 · Cited by 154
Lu, J., Patel, S. B., Sharma, N., Soisson, S. M., Kishii, R., Takei, M., Fukuda, Y., Lumb, K. J., & Singh, S. B. (2014) · ACS Chemical Biology · doi:10.1021/cb5001197 · Cited by 154
β-lactam/β-lactamase inhibitor combinations: an update
Tehrani, K. H. M. E., & Martin, N. I. (2018) · MedChemComm · doi:10.1039/c8md00342d · Cited by 153
Phage Therapy Regulation: From Night to Dawn
Fauconnier, A. (2019) · Viruses · doi:10.3390/v11040352 · Cited by 153
d’Angelo, I., Casciaro, B., Miro, A., Quaglia, F., Mangoni, M. L., & Ungaro, F. (2015) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2015.08.027 · Cited by 152
Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections
Thangamani, S., Younis, W., & Seleem, M. N. (2015) · Scientific Reports · doi:10.1038/srep11596 · Cited by 151
Ackerman, D. L., Doster, R. S., Weitkamp, J.-H., Aronoff, D. M., Gaddy, J. A., & Townsend, S. D. (2017) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00064 · Cited by 150
Biologically inspired strategies for combating bacterial biofilms
Blackledge, M. S., Worthington, R. J., & Melander, C. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.07.004 · Cited by 149
Antimicrobial and Antibiofilm Efficacy of Graphene Oxide against Chronic Wound Microorganisms
Giulio, M. D., Zappacosta, R., Lodovico, S. D., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00547-18 · Cited by 149
Bioengineering Lantibiotics for Therapeutic Success
Field, D., Cotter, P. D., Hill, C., & Ross, R. P. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01363 · Cited by 146
Murepavadin: a new antibiotic class in the pipeline
Martín‐Loeches, I., Dale, G. E., & Torres, A. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1441024 · Cited by 145
Yu, X., Robbie, G. J., Wu, Y., Esser, M. T., Jensen, K. M., Schwartz, H. I., Bellamy, T., Hernandez‐Illas, M., & Jafri, H. S. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01020-16 · Cited by 144
Leitner, L., Sybesma, W., Чанішвілі, Н., Goderdzishvili, M., Chkhotua, A. B., Ujmajuridze, A., Schneider, M. P., Sartori, A. M., Mehnert, U., Bachmann, L. M., et al. (2017) · BMC Urology · doi:10.1186/s12894-017-0283-6 · Cited by 144
Shortridge, D., Gales, A. C., Streit, J. M., Huband, M. D., Tsakris, A., & Jones, R. N. (2019) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy343 · Cited by 144
(2015) · doi:10.1016/j.jinf.2014.10.004 · Cited by 143
Chemical Strategies To Target Bacterial Virulence
Garland, M., Loscher, S., & Bogyo, M. S. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00676 · Cited by 143
Patey, O., McCallin, S. E., Mazure, H., Liddle, M., Smithyman, A. M., & Dublanchet, A. (2018) · Viruses · doi:10.3390/v11010018 · Cited by 140
Livermore, D. M., Mushtaq, S., Meunier, D., Hopkins, K. L., Hill, R., Adkin, R., Chaudhry, A., Pike, R., Staves, P., & Woodford, N. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx136 · Cited by 139
Ciprofloxacin-loaded PLGA nanoparticles against cystic fibrosis P. aeruginosa lung infections
Günday-Türeli, N., Torge, A., Juntke, J., Schwarz, B., Schneider‐Daum, N., Türeli, A. E., Lehr, C., & Schneider, M. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.04.032 · Cited by 137
Bacteriophages: A Therapy Concept against Multi-Drug–Resistant Bacteria
Rohde, C., Wittmann, J., & Kutter, E. M. (2018) · Surgical Infections · doi:10.1089/sur.2018.184 · Cited by 137
Stoesser, N. E., Mathers, A. J., Moore, C. E., Day, N., & Crook, D. W. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00010-4 · Cited by 136
Current Advances in Developing Inhibitors of Bacterial Multidrug Efflux Pumps
Mahmood, H. Y., Jamshidi, S., Sutton, J. M., & Rahman, K. M. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867323666160304150522 · Cited by 136
Bacteriophage therapy: a regulatory perspective
Pelfrene, E., Willebrand, E., Sanches, A., Sebris, Z., & Cavaleri, M. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkw083 · Cited by 133
A Wake-Up Call: We Need Phage Therapy Now
Moelling, K., Broecker, F., & Willy, C. (2018) · Viruses · doi:10.3390/v10120688 · Cited by 133
Avian Antimicrobial Host Defense Peptides: From Biology to Therapeutic Applications
Zhang, G., & Sunkara, L. T. (2014) · Pharmaceuticals · doi:10.3390/ph7030220 · Cited by 132
Lopes, L. A. A., Rodrigues, J. B. D. S., Magnani, M., de Souza, E. L., & Siqueira-Júnior, J. P. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.03.033 · Cited by 130
Engineered Cationic Antimicrobial Peptides To Overcome Multidrug Resistance by ESKAPE Pathogens
Deslouches, B., Steckbeck, J. D., Craigo, J. K., Doi, Y., Burns, J. L., & Montelaro, R. C. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03937-14 · Cited by 128
Efflux pump inhibitors (EPIs) as new antimicrobial agents against Pseudomonas aeruginosa
Askoura, M., Mattawa, W., Abujamel, T. S., & Taher, I. (2011) · Libyan Journal of Medicine · doi:10.3402/ljm.v6i0.5870 · Cited by 127
Zhang, Y., Dai, T., Wang, M., Vecchio, D., Chiang, L. Y., & Hamblin, M. R. (2015) · Nanomedicine · doi:10.2217/nnm.14.131 · Cited by 127
Dave, V., Yadav, R., Kushwaha, K., Yadav, S., Sharma, S. K., & Agrawal, U. (2017) · Bioactive Materials · doi:10.1016/j.bioactmat.2017.07.002 · Cited by 127
Prevention of ESKAPE pathogen biofilm formation by antimicrobial peptides WLBU2 and LL37
Lin, Q., Deslouches, B., Montelaro, R. C., & Di, Y. P. (2018) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2018.04.019 · Cited by 127
Wang, M., Wei, H., Zhao, Y., Shang, L., Di, L., Lyu, C., & Liu, J. (2018) · Bosnian Journal of Basic Medical Sciences · doi:10.17305/bjbms.2018.3826 · Cited by 127
ClpP Protease, a Promising Antimicrobial Target
Moreno-Cinos, C., Goossens, K., Salado, I. G., der Veken, P. V., Winter, H. L. D., & Augustyns, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092232 · Cited by 126
Biphasic release of gentamicin from chitosan/fucoidan nanoparticles for pulmonary delivery
Huang, Y., Li, R., Chen, J.-Y., & Chen, J. (2015) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2015.11.072 · Cited by 123
Self-citation
Cited by
Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections
Hu, X., Huang, Y.-Y., Wang, Y., Wang, X., & Hamblin, M. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01299 · Cited by 502
Advances in Antimicrobial Microneedle Patches for Combating Infections
Jamaledin, R., Yiu, C. K. Y., Zare, E. N., Niu, L., Vecchione, R., Chen, G., Gu, Z., Tay, F. R., & Makvandi, P. (2020) · Advanced Materials · doi:10.1002/adma.202002129 · Cited by 461
Self-citationOptimized arylomycins are a new class of Gram-negative antibiotics
Smith, P. A., Koehler, M. F. T., Girgis, H. S., Yan, D., Chen, Y., Chen, Y., Crawford, J. J., Durk, M. R., Higuchi, R. I., Kang, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0483-6 · Cited by 355
Liao, C., Huang, X., Wang, Q., Yao, D., & Lu, W. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.926758 · Cited by 309
Ferreira, R. L., da Silva, B. C. M., Rezende, G. S., Nakamura-Silva, R., Pitondo-Silva, A., Campanini, E. B., Brito, M. C. A., da Silva, E. M. L., Freire, C. C. D. M., Cunha, A. F. D., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03198 · Cited by 257
Metadata
- Authors
- Ma, Y., Wang, C., Li, Y., Li, J., Wan, Q., Chen, J., Tay, F. R., & Niu, L.
- Venue
- Advanced Science
- Publisher
- Wiley
- Published
- 2019-12-05
- Volume
- 7
- Issue
- 1
- Pages
- 1901872-1901872
- ISSN
- 2198-3844 (ISSN-L)
- OpenAlex
- W2992929975
- Cited by
- 314
- References
- 455
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.